Ruzanna Papyan: Opportunity to Join the Discussion on Future Directions in GD2-Targeted Therapy for Neuroblastoma
Ruzanna Papyan and Steven G. DuBois/LinkedIn

Ruzanna Papyan: Opportunity to Join the Discussion on Future Directions in GD2-Targeted Therapy for Neuroblastoma

Ruzanna Papyan, Chief of Pediatric Oncology Department at PCBDC of Armenia, shared on LinkedIn:

“Ready for our next Global Neuroblastoma Network Educational Session?

Join us on October 22 as we welcome Steven G. DuBois from Dana-Farber Cancer Institute to discuss: ‘Future Directions in GD2-Targeted Therapy: Lessons from the Paediatric Strategy Forum’.

Looking forward to another great discussion with our global neuroblastoma community!

October 22, 2026 | 8:30 AM Eastern Time

Join us here: ‘Future directions in GD2-targeted therapy: lessons from the Paediatric Strategy Forum’ with Dr. Steven DuBois – Global Neuroblastoma Network.”

Ruzanna Papyan

Other articles about neuroblastoma on OncoDaily.